Business
Allogene CEO Steps Down Amid Biotech News
David Chang, CEO of Allogene Therapeutics, is stepping down. Pfizer has invested billions in Chinese drugs and the WHO is mapping responses to an Ebola outbreak.
Coverage timeline — 1 article
STAT News
Pfizer invests billions to buy Chinese drugs, WHO maps experimental response to Ebola outbreak, and other biotech news from The Readout
2026-05-29 13:14 UTC